Veterinary Medicines

Maropitant Bioveta, 10mg/ml, Solution for injection

Authorised
  • Maropitant citrate monohydrate
Download as PDF

Product identification

Medicine name:
Maropitant Bioveta, 10mg/ml, Solution for injection
MAROPITANT Bioveta, 10 mg/ml, injekcinis tirpalas šunims ir katėms
Active substance:
  • Maropitant citrate monohydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Maropitant citrate monohydrate
    14.48
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA04AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Glass Vial 1 x 10.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/25/2863/001
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0192/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Cyprus
  • Estonia
  • France
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
Generic of:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 24/03/2025
Download